Abstract
The tumor-specific tetrabranched peptide NT4 binds membrane sulfate glycosaminoglycans and receptors belonging to the low density lipoprotein receptor-related protein (LRP) family, like LRP6, which are overexpressed in cancer. The binding occurs through a multimeric positively-charged motif of NT4 that interacts with negatively charged motives in both glycosaminoglycans and LRP receptors. LRP6 has an essential function in canonical Wnt signaling, acting together with receptors of the Frizzled family as coreceptor for Wnt ligands. The extracellular domain of LRP6 contains four YWTD β-propellers, which are fundamental for interactions with ligands, such as Wnt and Wnt inhibitors. To investigate the molecular interactions between the NT4 peptide and LRP6 receptor, we synthesized a library of epitope mapping peptides reproducing the YWTD β-propeller 3 and 4 of LRP6. The peptides that showed to bind NT4 represented the portion of LRP6 located on the top face of β-propeller 3 and contained negatively charged residues, including glutamic acid-708 which is known to be involved in Wnt3a interaction. The results pave the way for a possible development of peptide inhibitors of Wnt3a pathway to be used as drugs in oncology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahn VE, Chu ML, Choi HJ, Tran D, Abo A, Weis WI (2011) Structural basis of Wnt signaling inhibition by Dickkopf binding to LRP5/6. Dev Cell 21(5):862–873. https://doi.org/10.1016/j.devcel.2011.09.003
Bourhis E, Tam C, Franke Y, Bazan JF, Ernst J, Hwang J et al (2010) Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6. J Biol Chem 285(12):9172–9179. https://doi.org/10.1074/jbc.M109.092130
Bracci L, Falciani C, Lelli B, Lozzi L, Runci Y, Pini A et al (2003) Synthetic peptides in the form of dendrimers become resistant to protease activity. J Biol Chem 278:46590–46595
Bracci L, Mandarini E, Brunetti J, Depau L, Pini A, Terzuoli L et al (2018) The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells. PLoS ONE 13(3):e0194744. https://doi.org/10.1371/journal.pone.0194744
Brunetti J, Depau L, Falciani C, Gentile M, Mandarini E, Riolo G et al (2016) Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe. Sci Rep 6:27174. https://doi.org/10.1038/srep27174
Brunetti J, Falciani C, Lelli B, Minervini A, Ravenni N, Depau L et al (2015a) Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer. Biomed Res Int 2015:173507. https://doi.org/10.1155/2015/173507
Brunetti J, Pillozzi S, Falciani C, Depau L, Tenori E, Scali S et al (2015b) Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug. Sci Rep 5:17736. https://doi.org/10.1038/srep17736
Brunetti J, Riolo G, Depau L, Mandarini E, Bernini A, Karousou E et al (2019) Unraveling heparan sulfate proteoglycan binding motif for cancer cell selectivity. Front Oncol 9:843. https://doi.org/10.3389/fonc.2019.00843
Brunetti J, Riolo G, Gentile M, Bernini A, Paccagnini E, Falciani C et al (2018) Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging. J Nanobiotechnol 16:21. https://doi.org/10.1186/s12951-018-0346-1
Chen S, Bubeck D, MacDonald BT, Liang WX, Mao JH, Malinauskas T et al (2011) Structural and functional studies of LRP6 ectodomain reveal a platform for Wnt signaling. Dev Cell 21(5):848–861. https://doi.org/10.1016/j.devcel.2011.09.007
Chen J, Yan H, Ren DN, Yin Y, Li Z, He Q et al (2014) LRP6 dimerization through its LDLR domain is required for robust canonical Wnt pathway activation. Cell Signal 26(5):1068–1074. https://doi.org/10.1016/j.cellsig.2013.12.020
Cheng Z, Biechele T, Wei Z, Morrone S, Moon RT, Wang L et al (2011) Crystal structures of the extracellular domain of LRP6 and its complex with DKK1. Nat Struct Mol Biol 18:1204–1210. https://doi.org/10.1038/nsmb.2139
Clevers H, Nusse R (2012) Wnt/β-catenin signaling and disease. Cell 149(6):1192–1205. https://doi.org/10.1016/j.cell.2012.05.012
Cruciat CM, Niehrs C (2013) Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harb Perspect Biol 5:a015081. https://doi.org/10.1101/cshperspect.a015081
Depau L, Brunetti J, Falciani C, Scali S, Riolo G, Mandarini E et al (2017) Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate. Oncotarget 8:76141–76152. https://doi.org/10.18632/oncotarget.19056
Ettenberg SA, Charlat O, Daley MP, Liu S, Vincent KJ, Stuart DD et al (2010) Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies. Proc Natl Acad Sci USA 107(35):15473–15478. https://doi.org/10.1073/pnas.1007428107
Falciani C, Accardo A, Brunetti J, Tesauro D, Lelli B, Pini A et al (2011) Target-selective drug delivery through liposomes labeled with oligobranched neurotensin peptides. ChemMedChem 6(4):678–685. https://doi.org/10.1002/cmdc.201000463
Falciani C, Brunetti J, Lelli B, Ravenni N, Lozzi L, Depau L et al (2013) Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. J Med Chem 56(12):5009–5018. https://doi.org/10.1021/jm400329p
Falciani C, Brunetti J, Pagliuca C, Menichetti S, Vitellozzi L, Lelli B et al (2010a) Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents. ChemMedChem 5:567–574. https://doi.org/10.1002/cmdc.200900527
Falciani C, Fabbrini M, Pini A, Lozzi L, Lelli B, Pileri S et al (2007) Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting. Mol Cancer Ther 6(9):2441–2448. https://doi.org/10.1158/1535-7163.MCT-07-0164
Falciani C, Lelli B, Brunetti J, Pileri S, Cappelli A, Pini A et al (2010b) Modular branched neurotensin peptides for tumor target tracing and receptor-mediated therapy: a proof-of-concept. Curr Cancer Drug Targets 10(7):695–704. https://doi.org/10.2174/156800910793605875
Frank R (1992) Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48:9217–9232. https://doi.org/10.1016/S0040-4020(01)85612-X
Frank R (2002) The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports–principles and applications. J Immunol Methods 267(1):13–26. https://doi.org/10.1016/S0022-1759(02)00137-0
Gong Y, Bourhis E, Chiu C, Stawicki S, DeAlmeida VI, Liu BY et al (2010) Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies. PLoS ONE 5(9):e12682. https://doi.org/10.1371/journal.pone.0012682
He X, Semenov M, Tamai K, Zeng X (2004) LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131:1663–1677. https://doi.org/10.1242/dev.01117
Holdsworth G, Slocombe P, Doyle C, Sweeney B, Veverka V, Le Riche K et al (2012) Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors. J Biol Chem 287:26464–26477. https://doi.org/10.1074/jbc.M112.350108
Jeon H, Meng W, Takagi J, Eck MJ, Springer TA, Blacklow SC (2001) Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair. Nat Struct Biol 8:499–504. https://doi.org/10.1038/88556
Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J et al (2005) Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 280:19883–19887. https://doi.org/10.1074/jbc.M413274200
Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810. https://doi.org/10.1146/annurev.cellbio.20.010403.113126
MacDonald BT, Semenov MV, Huang H, He X (2011) Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6. PLoS ONE 6(8):e23537. https://doi.org/10.1371/journal.pone.0023537
MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17(1):9–26. https://doi.org/10.1016/j.devcel.2009.06.016
Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411:321–325. https://doi.org/10.1038/35077108
Niehrs C (2012) The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol 13:767–779. https://doi.org/10.1038/nrm3470
Nusse R, Clevers H (2017) Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell 169(6):985–999. https://doi.org/10.1016/j.cell.2017.05.016
Ocaña OH, Córcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S et al (2012) Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22(6):709–724. https://doi.org/10.1016/j.ccr.2012.10.012
Pinson KI, Brennan J, Monkley S, Avery BJ, Skames WC (2000) An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407:535–538. https://doi.org/10.1038/35035124
Semënov M, Tamai K, He X (2005) SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 280(29):26770–26775. https://doi.org/10.1074/jbc.M504308200
Tam JP (1998) Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci USA 85:5409–5413
Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y et al (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407:530–535. https://doi.org/10.1038/35035117
Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36:1461–1473. https://doi.org/10.1038/onc.2016.304
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Handling editor: Z. Cheng.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Brunetti, J., Falciani, C., Bernini, A. et al. Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor. Amino Acids 52, 915–924 (2020). https://doi.org/10.1007/s00726-020-02860-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-020-02860-1